| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 CREBBP EP300 KAT6A | 2.08e-19 | 303 | 26 | 14 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 CREBBP EP300 KAT6A | 1.18e-15 | 562 | 26 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 CREBBP CAPRIN1 EP300 KAT6A TNRC6A | 4.66e-14 | 1160 | 26 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 CREBBP CAPRIN1 EP300 KAT6A TNRC6A | 5.21e-13 | 1356 | 26 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.05e-09 | 15 | 26 | 4 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 5.61e-09 | 51 | 26 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.28e-09 | 55 | 26 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.29e-08 | 60 | 26 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.33e-08 | 21 | 26 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.93e-08 | 78 | 26 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.90e-07 | 102 | 26 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.10e-07 | 104 | 26 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.20e-07 | 739 | 26 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone modifying activity | 4.05e-07 | 229 | 26 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.12e-06 | 61 | 26 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.63e-06 | 2 | 26 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.63e-06 | 2 | 26 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.46e-06 | 86 | 26 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.89e-06 | 3 | 26 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.24e-05 | 238 | 26 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.70e-05 | 753 | 26 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 4.45e-05 | 775 | 26 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 5.84e-05 | 9 | 26 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 8.36e-05 | 582 | 26 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.48e-05 | 187 | 26 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.78e-04 | 417 | 26 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.05e-04 | 20 | 26 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 4.06e-04 | 23 | 26 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.97e-04 | 120 | 26 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 8.40e-04 | 33 | 26 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.91e-04 | 34 | 26 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.06e-03 | 37 | 26 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 1.17e-03 | 39 | 26 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.16e-03 | 53 | 26 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.24e-03 | 54 | 26 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.32e-03 | 66 | 26 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.32e-03 | 66 | 26 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | p53 binding | 4.49e-03 | 77 | 26 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.26e-03 | 891 | 26 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 5.32e-03 | 84 | 26 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.60e-03 | 560 | 26 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.82e-03 | 566 | 26 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | nucleosome binding | 7.18e-03 | 98 | 26 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 9.74e-03 | 1459 | 26 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.42e-02 | 140 | 26 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.71e-02 | 1189 | 26 | 5 | GO:0046914 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.98e-02 | 167 | 26 | 2 | GO:0031490 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L NCOA3 NCOA6 ZFHX3 KMT2D ZMIZ1 BCL9 SSBP3 KAT6B NFAT5 SS18 CREBBP EP300 SMAD1 | 1.67e-10 | 1390 | 26 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | NCOA3 ARID1B KMT2D ARID1A KAT6B NFAT5 SS18 CREBBP EP300 KAT6A | 1.06e-08 | 741 | 26 | 10 | GO:0006338 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.32e-08 | 237 | 26 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.53e-08 | 242 | 26 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | chromatin organization | NCOA3 ARID1B KMT2D ARID1A KAT6B NFAT5 SS18 CREBBP EP300 KAT6A | 6.41e-08 | 896 | 26 | 10 | GO:0006325 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.66e-07 | 343 | 26 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NCOA3 ARID1B KMT2D ARID1A KAT6B NFAT5 SS18 CREBBP EP300 KAT6A | 1.77e-07 | 999 | 26 | 10 | GO:0071824 |
| GeneOntologyBiologicalProcess | head morphogenesis | 3.72e-07 | 48 | 26 | 4 | GO:0060323 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 NCOA6 KMT2D ZMIZ1 SSBP3 ARID1A CREBBP EP300 SMAD1 ROR2 KAT6A | 5.25e-07 | 1437 | 26 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BCL9L NCOA3 ZFHX3 ARID1B ZMIZ1 ARID1A CAPRIN1 EP300 SMAD1 ROR2 | 6.07e-07 | 1141 | 26 | 10 | GO:0045597 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 6.81e-07 | 136 | 26 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 6.81e-07 | 136 | 26 | 5 | GO:0045445 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 9.57e-07 | 445 | 26 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.00e-06 | 276 | 26 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 1.15e-06 | 1223 | 26 | 10 | GO:0030097 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 1.20e-06 | 64 | 26 | 4 | GO:0010171 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.30e-06 | 155 | 26 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.63e-06 | 482 | 26 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.12e-06 | 336 | 26 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 3.46e-06 | 540 | 26 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 4.77e-06 | 202 | 26 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | response to growth factor | 8.58e-06 | 883 | 26 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 9.15e-06 | 4 | 26 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.04e-05 | 906 | 26 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.08e-05 | 239 | 26 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.15e-05 | 242 | 26 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.15e-05 | 242 | 26 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | head development | 1.15e-05 | 919 | 26 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.19e-05 | 244 | 26 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.24e-05 | 929 | 26 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.84e-05 | 41 | 26 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 3.02e-05 | 144 | 26 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 3.56e-05 | 51 | 26 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.56e-05 | 51 | 26 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 4.07e-05 | 1095 | 26 | 8 | GO:0060284 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 4.19e-05 | 317 | 26 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 4.23e-05 | 54 | 26 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.79e-05 | 162 | 26 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 4.97e-05 | 57 | 26 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 6.51e-05 | 850 | 26 | 7 | GO:0071363 | |
| GeneOntologyBiologicalProcess | face development | 6.72e-05 | 63 | 26 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 6.80e-05 | 579 | 26 | 6 | GO:0045785 | |
| GeneOntologyBiologicalProcess | muscle structure development | 6.91e-05 | 858 | 26 | 7 | GO:0061061 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 7.18e-05 | 1186 | 26 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 7.37e-05 | 65 | 26 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | protein acetylation | 8.44e-05 | 68 | 26 | 3 | GO:0006473 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 8.44e-05 | 68 | 26 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 8.67e-05 | 605 | 26 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 9.27e-05 | 192 | 26 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 9.40e-05 | 614 | 26 | 6 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 9.84e-05 | 195 | 26 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 1.00e-04 | 12 | 26 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.00e-04 | 381 | 26 | 5 | GO:0048545 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.10e-04 | 389 | 26 | 5 | GO:0022409 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.27e-04 | 78 | 26 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | DNA damage response | 1.39e-04 | 959 | 26 | 7 | GO:0006974 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.51e-04 | 416 | 26 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.74e-04 | 226 | 26 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.74e-04 | 429 | 26 | 5 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.76e-04 | 87 | 26 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.81e-04 | 16 | 26 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.81e-04 | 16 | 26 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.89e-04 | 231 | 26 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 2.07e-04 | 92 | 26 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 2.11e-04 | 447 | 26 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 2.28e-04 | 95 | 26 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 2.31e-04 | 18 | 26 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | response to hormone | 2.32e-04 | 1042 | 26 | 7 | GO:0009725 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 2.36e-04 | 727 | 26 | 6 | GO:0032870 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.40e-04 | 1048 | 26 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 2.85e-04 | 1446 | 26 | 8 | GO:0010628 | |
| GeneOntologyBiologicalProcess | heart development | 2.94e-04 | 757 | 26 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 3.11e-04 | 486 | 26 | 5 | GO:0007159 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.23e-04 | 266 | 26 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | protein acylation | 3.32e-04 | 108 | 26 | 3 | GO:0043543 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 3.32e-04 | 108 | 26 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 3.51e-04 | 110 | 26 | 3 | GO:0060395 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 3.80e-04 | 23 | 26 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 3.80e-04 | 23 | 26 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 3.80e-04 | 23 | 26 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.48e-04 | 290 | 26 | 4 | GO:0050870 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 5.66e-04 | 28 | 26 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 5.85e-04 | 558 | 26 | 5 | GO:0030099 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 5.85e-04 | 558 | 26 | 5 | GO:0060537 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 5.99e-04 | 561 | 26 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 6.07e-04 | 29 | 26 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 6.07e-04 | 29 | 26 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 6.96e-04 | 580 | 26 | 5 | GO:0022407 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 7.25e-04 | 141 | 26 | 3 | GO:0060996 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 7.28e-04 | 330 | 26 | 4 | GO:0040029 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 7.40e-04 | 142 | 26 | 3 | GO:0034728 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 7.55e-04 | 143 | 26 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | developmental growth | 7.86e-04 | 911 | 26 | 6 | GO:0048589 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 8.02e-04 | 146 | 26 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 8.61e-04 | 927 | 26 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.78e-04 | 347 | 26 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 8.86e-04 | 35 | 26 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 8.86e-04 | 35 | 26 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 9.38e-04 | 36 | 26 | 2 | GO:0034063 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 9.38e-04 | 36 | 26 | 2 | GO:0033146 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.16e-09 | 596 | 26 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | NCOA3 ZFHX3 ARID1B ZMIZ1 ARID1A KAT6B NFAT5 SS18 CREBBP EP300 SMAD1 KAT6A | 5.76e-08 | 1480 | 26 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA3 NCOA6 ARID1B KMT2D BCL9 ARID1A SS18 CREBBP WDR33 SMAD1 | 2.99e-07 | 1377 | 26 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 6.16e-07 | 14 | 26 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.31e-06 | 94 | 26 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.78e-06 | 30 | 26 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 7.94e-06 | 104 | 26 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 9.57e-06 | 109 | 26 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.89e-05 | 272 | 26 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 3.11e-05 | 7 | 26 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 4.15e-05 | 8 | 26 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | bBAF complex | 6.65e-05 | 10 | 26 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 9.74e-05 | 12 | 26 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.15e-04 | 13 | 26 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | transferase complex | 1.31e-04 | 963 | 26 | 7 | GO:1990234 | |
| GeneOntologyCellularComponent | brahma complex | 1.34e-04 | 14 | 26 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.77e-04 | 16 | 26 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.26e-04 | 96 | 26 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 5.38e-04 | 129 | 26 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.90e-03 | 75 | 26 | 2 | GO:0035097 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.40e-03 | 269 | 26 | 3 | GO:0036464 | |
| GeneOntologyCellularComponent | nuclear body | 4.59e-03 | 903 | 26 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.27e-03 | 287 | 26 | 3 | GO:0035770 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 6.26e-03 | 972 | 26 | 5 | GO:0140535 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 6.31e-03 | 96 | 26 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | P-body | 7.10e-03 | 102 | 26 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | methyltransferase complex | 7.93e-03 | 108 | 26 | 2 | GO:0034708 | |
| GeneOntologyCellularComponent | PML body | 1.05e-02 | 125 | 26 | 2 | GO:0016605 | |
| GeneOntologyCellularComponent | nucleosome | 1.27e-02 | 138 | 26 | 2 | GO:0000786 | |
| GeneOntologyCellularComponent | nuclear speck | 1.59e-02 | 431 | 26 | 3 | GO:0016607 | |
| GeneOntologyCellularComponent | fibrillar center | 1.60e-02 | 156 | 26 | 2 | GO:0001650 | |
| HumanPheno | Low hanging columella | 1.18e-09 | 56 | 12 | 6 | HP:0009765 | |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B KMT2D ZMIZ1 ARID1A KAT6B CREBBP CAPRIN1 EP300 ROR2 KAT6A | 2.00e-09 | 464 | 12 | 10 | HP:0011339 |
| HumanPheno | Thin upper lip vermilion | 4.25e-09 | 339 | 12 | 9 | HP:0000219 | |
| HumanPheno | Thin lips | 4.25e-09 | 339 | 12 | 9 | HP:0000213 | |
| HumanPheno | Sandal gap | 3.23e-08 | 96 | 12 | 6 | HP:0001852 | |
| HumanPheno | Abnormal columella morphology | 3.44e-08 | 97 | 12 | 6 | HP:0009929 | |
| HumanPheno | Prominent fingertip pads | 3.63e-08 | 46 | 12 | 5 | HP:0001212 | |
| HumanPheno | Thin vermilion border | 3.74e-08 | 433 | 12 | 9 | HP:0000233 | |
| HumanPheno | Prominent digit pad | 4.52e-08 | 48 | 12 | 5 | HP:0011298 | |
| HumanPheno | Abnormal nasal septum morphology | 9.61e-08 | 115 | 12 | 6 | HP:0000419 | |
| HumanPheno | Abnormal hallux morphology | 1.30e-07 | 212 | 12 | 7 | HP:0001844 | |
| HumanPheno | Long eyelashes | 1.92e-07 | 129 | 12 | 6 | HP:0000527 | |
| HumanPheno | Congenital malformation of the great arteries | 2.18e-07 | 529 | 12 | 9 | HP:0011603 | |
| HumanPheno | Abnormality of dental eruption | 3.06e-07 | 240 | 12 | 7 | HP:0006292 | |
| HumanPheno | Hypospadias | 3.18e-07 | 377 | 12 | 8 | HP:0000047 | |
| HumanPheno | Patent ductus arteriosus | 3.53e-07 | 382 | 12 | 8 | HP:0001643 | |
| HumanPheno | Broad hallux | 4.73e-07 | 76 | 12 | 5 | HP:0010055 | |
| HumanPheno | Displacement of the urethral meatus | 4.76e-07 | 397 | 12 | 8 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 4.95e-07 | 399 | 12 | 8 | HP:0032076 | |
| HumanPheno | Hydronephrosis | 5.88e-07 | 264 | 12 | 7 | HP:0000126 | |
| HumanPheno | Intestinal malrotation | 6.18e-07 | 157 | 12 | 6 | HP:0002566 | |
| HumanPheno | Pilomatrixoma | 8.33e-07 | 9 | 12 | 3 | HP:0030434 | |
| HumanPheno | Brachydactyly (hand) | 8.85e-07 | 430 | 12 | 8 | HP:0100667 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 9.33e-07 | 87 | 12 | 5 | HP:0000614 | |
| HumanPheno | Broad toe | 9.33e-07 | 87 | 12 | 5 | HP:0001837 | |
| HumanPheno | Nasolacrimal duct obstruction | 9.99e-07 | 36 | 12 | 4 | HP:0000579 | |
| HumanPheno | Dilatation of the renal pelvis | 1.12e-06 | 290 | 12 | 7 | HP:0010946 | |
| HumanPheno | Abnormal renal pelvis morphology | 1.41e-06 | 300 | 12 | 7 | HP:0010944 | |
| HumanPheno | Abnormality of the helix | 1.53e-06 | 183 | 12 | 6 | HP:0000380 | |
| HumanPheno | Abnormal external nose morphology | ARID1B KMT2D ZMIZ1 ARID1A KAT6B CREBBP CAPRIN1 EP300 ROR2 KAT6A | 1.57e-06 | 916 | 12 | 10 | HP:0010938 |
| HumanPheno | Short phalanx of finger | 1.61e-06 | 306 | 12 | 7 | HP:0009803 | |
| HumanPheno | Abnormality of the urethra | 1.62e-06 | 465 | 12 | 8 | HP:0000795 | |
| HumanPheno | Brachydactyly | 1.70e-06 | 670 | 12 | 9 | HP:0001156 | |
| HumanPheno | Short digit | 1.75e-06 | 672 | 12 | 9 | HP:0011927 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 2.13e-06 | 319 | 12 | 7 | HP:0009767 | |
| HumanPheno | Short finger | 2.42e-06 | 325 | 12 | 7 | HP:0009381 | |
| HumanPheno | Abnormal upper lip morphology | ARID1B KMT2D ZMIZ1 ARID1A KAT6B CREBBP CAPRIN1 EP300 ROR2 KAT6A | 3.02e-06 | 980 | 12 | 10 | HP:0000177 |
| HumanPheno | Abnormal 5th finger morphology | 3.25e-06 | 509 | 12 | 8 | HP:0004207 | |
| HumanPheno | Ventricular septal defect | 3.30e-06 | 510 | 12 | 8 | HP:0001629 | |
| HumanPheno | Abnormality of the philtrum | 3.41e-06 | 726 | 12 | 9 | HP:0000288 | |
| HumanPheno | Abnormal helix morphology | 3.63e-06 | 212 | 12 | 6 | HP:0011039 | |
| HumanPheno | Abnormal morphology of the great vessels | 3.83e-06 | 736 | 12 | 9 | HP:0030962 | |
| HumanPheno | Abnormal lacrimal duct morphology | 3.84e-06 | 50 | 12 | 4 | HP:0011481 | |
| HumanPheno | Abnormal ventricular septum morphology | 3.88e-06 | 521 | 12 | 8 | HP:0010438 | |
| HumanPheno | Single transverse palmar crease | 3.94e-06 | 215 | 12 | 6 | HP:0000954 | |
| HumanPheno | Ptosis | 4.72e-06 | 754 | 12 | 9 | HP:0000508 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 4.96e-06 | 538 | 12 | 8 | HP:0005927 | |
| HumanPheno | Aplasia involving bones of the extremities | 4.99e-06 | 759 | 12 | 9 | HP:0009825 | |
| HumanPheno | Plantar crease between first and second toes | 5.09e-06 | 2 | 12 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 5.09e-06 | 2 | 12 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 5.09e-06 | 2 | 12 | 2 | HP:0001042 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 5.10e-06 | 761 | 12 | 9 | HP:0045060 | |
| HumanPheno | Atrial septal defect | 5.18e-06 | 541 | 12 | 8 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 5.18e-06 | 541 | 12 | 8 | HP:0001630 | |
| HumanPheno | Dislocated radial head | 5.24e-06 | 54 | 12 | 4 | HP:0003083 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 5.40e-06 | 366 | 12 | 7 | HP:0006265 | |
| HumanPheno | Abnormal atrial septum morphology | 5.40e-06 | 544 | 12 | 8 | HP:0011994 | |
| HumanPheno | Cryptorchidism | 6.31e-06 | 780 | 12 | 9 | HP:0000028 | |
| HumanPheno | Retrognathia | 6.36e-06 | 375 | 12 | 7 | HP:0000278 | |
| HumanPheno | Joint hypermobility | 6.46e-06 | 557 | 12 | 8 | HP:0001382 | |
| HumanPheno | Abnormality of the radial head | 6.53e-06 | 57 | 12 | 4 | HP:0003995 | |
| HumanPheno | Premature thelarche | 6.67e-06 | 17 | 12 | 3 | HP:0010314 | |
| HumanPheno | Prominent eyelashes | 6.67e-06 | 17 | 12 | 3 | HP:0011231 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 7.91e-06 | 572 | 12 | 8 | HP:0006496 | |
| HumanPheno | Skin appendage neoplasm | 7.99e-06 | 18 | 12 | 3 | HP:0012842 | |
| HumanPheno | Clinodactyly | 8.13e-06 | 574 | 12 | 8 | HP:0030084 | |
| HumanPheno | Abnormal earlobe morphology | 8.90e-06 | 137 | 12 | 5 | HP:0000363 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 8.99e-06 | 813 | 12 | 9 | HP:0009815 | |
| HumanPheno | Abnormality of the humeroradial joint | 9.16e-06 | 62 | 12 | 4 | HP:0100744 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 9.90e-06 | 140 | 12 | 5 | HP:0001991 | |
| HumanPheno | Short 5th finger | 1.04e-05 | 64 | 12 | 4 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.18e-05 | 66 | 12 | 4 | HP:0006262 | |
| HumanPheno | Abnormality of the palmar creases | 1.19e-05 | 260 | 12 | 6 | HP:0010490 | |
| HumanPheno | Micrognathia | 1.22e-05 | 843 | 12 | 9 | HP:0000347 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | 1.25e-05 | 845 | 12 | 9 | HP:0009118 | |
| HumanPheno | Low anterior hairline | 1.26e-05 | 147 | 12 | 5 | HP:0000294 | |
| HumanPheno | Localized hirsutism | 1.30e-05 | 21 | 12 | 3 | HP:0009889 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 1.33e-05 | 265 | 12 | 6 | HP:0001018 | |
| HumanPheno | Epicanthus | 1.35e-05 | 614 | 12 | 8 | HP:0000286 | |
| HumanPheno | Clinodactyly of the 5th finger | 1.36e-05 | 420 | 12 | 7 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 1.38e-05 | 421 | 12 | 7 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.38e-05 | 421 | 12 | 7 | HP:0009179 | |
| HumanPheno | Abnormal cardiac atrium morphology | 1.41e-05 | 617 | 12 | 8 | HP:0005120 | |
| HumanPheno | Abnormality of mouth size | 1.47e-05 | 425 | 12 | 7 | HP:0011337 | |
| HumanPheno | Laryngeal cartilage malformation | 1.52e-05 | 3 | 12 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.52e-05 | 3 | 12 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.52e-05 | 3 | 12 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.52e-05 | 3 | 12 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.52e-05 | 3 | 12 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.52e-05 | 3 | 12 | 2 | HP:0005895 | |
| HumanPheno | Abnormality of the scalp hair | 1.66e-05 | 433 | 12 | 7 | HP:0100037 | |
| HumanPheno | Abnormality of tear glands or tear production | 1.68e-05 | 156 | 12 | 5 | HP:0000521 | |
| HumanPheno | Aplasia of the toes | 1.86e-05 | 74 | 12 | 4 | HP:0011306 | |
| HumanPheno | Absent toe | 1.86e-05 | 74 | 12 | 4 | HP:0010760 | |
| HumanPheno | Abnormal cheek morphology | 1.90e-05 | 282 | 12 | 6 | HP:0004426 | |
| HumanPheno | Broad hallux phalanx | 1.97e-05 | 24 | 12 | 3 | HP:0010059 | |
| HumanPheno | Abnormal eyelash morphology | 1.98e-05 | 284 | 12 | 6 | HP:0000499 | |
| HumanPheno | Abnormal toe morphology | 2.00e-05 | 893 | 12 | 9 | HP:0001780 | |
| HumanPheno | Radial deviation of finger | 2.08e-05 | 448 | 12 | 7 | HP:0009466 | |
| HumanPheno | Abnormal scalp morphology | 2.15e-05 | 450 | 12 | 7 | HP:0001965 | |
| MousePheno | abnormal prenatal body size | BCL9L ATXN2L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A CREBBP CAPRIN1 EP300 SMAD1 MAEA ROR2 KAT6A | 4.75e-11 | 1116 | 25 | 15 | MP:0010866 |
| MousePheno | abnormal prenatal growth/weight/body size | BCL9L ATXN2L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP CAPRIN1 EP300 SMAD1 MAEA ROR2 KAT6A | 2.12e-10 | 1493 | 25 | 16 | MP:0004196 |
| MousePheno | decreased embryo size | BCL9L NCOA3 NCOA6 ZMIZ1 SSBP3 ARID1A CREBBP EP300 SMAD1 ROR2 | 8.70e-08 | 659 | 25 | 10 | MP:0001698 |
| MousePheno | embryonic lethality during organogenesis | BCL9L ATXN2L NCOA6 KMT2D ZMIZ1 SSBP3 ARID1A CREBBP EP300 SMAD1 TNRC6A | 1.09e-07 | 876 | 25 | 11 | MP:0006207 |
| MousePheno | abnormal embryo size | BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A CREBBP EP300 SMAD1 ROR2 | 2.64e-07 | 956 | 25 | 11 | MP:0001697 |
| MousePheno | abnormal embryonic growth/weight/body size | BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP EP300 SMAD1 ROR2 | 6.29e-07 | 1295 | 25 | 12 | MP:0002088 |
| MousePheno | craniofacial phenotype | NCOA3 NCOA6 KMT2D ZMIZ1 SSBP3 KAT6B PNISR CREBBP EP300 SMAD1 ROR2 KAT6A | 1.17e-06 | 1372 | 25 | 12 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | NCOA3 NCOA6 KMT2D ZMIZ1 SSBP3 KAT6B PNISR CREBBP EP300 SMAD1 ROR2 KAT6A | 1.17e-06 | 1372 | 25 | 12 | MP:0000428 |
| MousePheno | abnormal extraembryonic tissue morphology | BCL9L NCOA6 ZMIZ1 ARID1A SS18 CREBBP EP300 SMAD1 ROR2 TNRC6A | 1.70e-06 | 908 | 25 | 10 | MP:0002086 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 1.86e-06 | 700 | 25 | 9 | MP:0011098 | |
| MousePheno | pallor | 3.16e-06 | 239 | 25 | 6 | MP:0003717 | |
| MousePheno | abnormal myocardium compact layer morphology | 5.65e-06 | 67 | 25 | 4 | MP:0004056 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 6.12e-06 | 268 | 25 | 6 | MP:0011108 | |
| MousePheno | perinatal lethality | NCOA6 ARID1B ARID1A NFAT5 CREBBP CAPRIN1 EP300 MAEA ROR2 KAT6A | 1.21e-05 | 1130 | 25 | 10 | MP:0002081 |
| MousePheno | perinatal lethality, complete penetrance | 2.17e-05 | 712 | 25 | 8 | MP:0011089 | |
| MousePheno | decreased cell proliferation | 2.84e-05 | 739 | 25 | 8 | MP:0000352 | |
| MousePheno | short facial bone | 3.24e-05 | 104 | 25 | 4 | MP:0030384 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NCOA6 ARID1B ARID1A NFAT5 CREBBP CAPRIN1 EP300 MAEA ROR2 KAT6A | 3.36e-05 | 1269 | 25 | 10 | MP:0011111 |
| MousePheno | pale yolk sac | 4.04e-05 | 110 | 25 | 4 | MP:0001722 | |
| MousePheno | abnormal visceral yolk sac morphology | 5.30e-05 | 236 | 25 | 5 | MP:0001718 | |
| MousePheno | abnormal cranium morphology | 5.63e-05 | 813 | 25 | 8 | MP:0000438 | |
| MousePheno | abnormal gas homeostasis | 6.33e-05 | 600 | 25 | 7 | MP:0003948 | |
| MousePheno | abnormal craniofacial bone morphology | 6.36e-05 | 827 | 25 | 8 | MP:0002116 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 6.77e-05 | 410 | 25 | 6 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 6.77e-05 | 410 | 25 | 6 | MP:0011102 | |
| MousePheno | thin myocardium compact layer | 7.29e-05 | 46 | 25 | 3 | MP:0004057 | |
| MousePheno | abnormal oxygen level | 7.80e-05 | 256 | 25 | 5 | MP:0001574 | |
| MousePheno | abnormal embryonic tissue morphology | 8.05e-05 | 1116 | 25 | 9 | MP:0002085 | |
| MousePheno | abnormal head morphology | 8.28e-05 | 1120 | 25 | 9 | MP:0000432 | |
| MousePheno | ventricular septal defect | 8.54e-05 | 261 | 25 | 5 | MP:0010402 | |
| MousePheno | lethality throughout fetal growth and development | 9.39e-05 | 435 | 25 | 6 | MP:0006208 | |
| MousePheno | abnormal myocardial trabeculae morphology | 1.15e-04 | 144 | 25 | 4 | MP:0002189 | |
| MousePheno | kinked neural tube | 1.39e-04 | 57 | 25 | 3 | MP:0003400 | |
| MousePheno | abnormal skin appearance | 1.49e-04 | 473 | 25 | 6 | MP:0009931 | |
| MousePheno | flattened snout | 2.00e-04 | 12 | 25 | 2 | MP:0000447 | |
| MousePheno | abnormal nervous system development | 2.02e-04 | 1257 | 25 | 9 | MP:0003861 | |
| MousePheno | incomplete embryo turning | 2.05e-04 | 65 | 25 | 3 | MP:0001701 | |
| MousePheno | abnormal blood cell morphology/development | 2.18e-04 | 986 | 25 | 8 | MP:0002429 | |
| MousePheno | abnormal placenta morphology | 2.62e-04 | 525 | 25 | 6 | MP:0001711 | |
| MousePheno | ventricle myocardium hypoplasia | 2.67e-04 | 71 | 25 | 3 | MP:0010502 | |
| MousePheno | abnormal jaw morphology | 2.76e-04 | 530 | 25 | 6 | MP:0000454 | |
| MousePheno | increased grooming behavior | 3.01e-04 | 74 | 25 | 3 | MP:0001441 | |
| MousePheno | abnormal chorion morphology | 3.01e-04 | 74 | 25 | 3 | MP:0002836 | |
| MousePheno | abnormal interventricular septum morphology | 3.02e-04 | 342 | 25 | 5 | MP:0000281 | |
| MousePheno | abnormal vascular development | 3.12e-04 | 542 | 25 | 6 | MP:0000259 | |
| MousePheno | abnormal extraembryonic tissue physiology | 3.15e-04 | 345 | 25 | 5 | MP:0004264 | |
| MousePheno | abnormal chorionic plate morphology | 3.18e-04 | 15 | 25 | 2 | MP:0004560 | |
| MousePheno | embryonic growth arrest | 3.19e-04 | 346 | 25 | 5 | MP:0001730 | |
| MousePheno | abnormal heart ventricle morphology | 3.60e-04 | 793 | 25 | 7 | MP:0005294 | |
| MousePheno | abnormal forebrain morphology | 3.87e-04 | 1072 | 25 | 8 | MP:0000783 | |
| MousePheno | abnormal embryo development | 3.88e-04 | 1370 | 25 | 9 | MP:0001672 | |
| MousePheno | abnormal epicardium morphology | 4.11e-04 | 17 | 25 | 2 | MP:0003057 | |
| MousePheno | myocardium hypoplasia | 4.69e-04 | 86 | 25 | 3 | MP:0010500 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 4.71e-04 | 208 | 25 | 4 | MP:0011109 | |
| MousePheno | abnormal muscle morphology | 4.78e-04 | 1106 | 25 | 8 | MP:0002108 | |
| MousePheno | abnormal neural tube morphology | 4.95e-04 | 591 | 25 | 6 | MP:0002151 | |
| MousePheno | atrial septal defect | 5.02e-04 | 88 | 25 | 3 | MP:0010403 | |
| MousePheno | abnormal viscerocranium morphology | 5.04e-04 | 593 | 25 | 6 | MP:0005274 | |
| MousePheno | abnormal heart septum morphology | 5.39e-04 | 388 | 25 | 5 | MP:0006113 | |
| MousePheno | perimembraneous ventricular septal defect | 5.71e-04 | 92 | 25 | 3 | MP:0010418 | |
| MousePheno | thin ventricle myocardium compact layer | 5.72e-04 | 20 | 25 | 2 | MP:0010556 | |
| MousePheno | decreased circulating glucagon level | 5.72e-04 | 20 | 25 | 2 | MP:0002696 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 5.90e-04 | 93 | 25 | 3 | MP:0008823 | |
| MousePheno | abnormal pericardium morphology | 6.34e-04 | 225 | 25 | 4 | MP:0000288 | |
| MousePheno | open neural tube | 6.44e-04 | 226 | 25 | 4 | MP:0000929 | |
| MousePheno | cyanosis | 6.44e-04 | 226 | 25 | 4 | MP:0001575 | |
| MousePheno | abnormal blood vessel morphology | 6.62e-04 | 1472 | 25 | 9 | MP:0001614 | |
| MousePheno | decreased fetal size | 6.77e-04 | 229 | 25 | 4 | MP:0004200 | |
| MousePheno | absent myocardial trabeculae | 6.94e-04 | 22 | 25 | 2 | MP:0000293 | |
| MousePheno | ventricular hypoplasia | 7.08e-04 | 99 | 25 | 3 | MP:0000279 | |
| MousePheno | abnormal heart atrium morphology | 7.11e-04 | 232 | 25 | 4 | MP:0003105 | |
| MousePheno | abnormal myocardium layer morphology | 7.24e-04 | 414 | 25 | 5 | MP:0005329 | |
| MousePheno | abnormal vitelline vasculature morphology | 7.46e-04 | 235 | 25 | 4 | MP:0003229 | |
| MousePheno | abnormal fetal size | 7.70e-04 | 237 | 25 | 4 | MP:0004198 | |
| MousePheno | abnormal heart layer morphology | 7.89e-04 | 422 | 25 | 5 | MP:0010545 | |
| MousePheno | heart hypoplasia | 7.94e-04 | 103 | 25 | 3 | MP:0002740 | |
| MousePheno | abnormal craniofacial development | 8.15e-04 | 425 | 25 | 5 | MP:0003935 | |
| MousePheno | abnormal facial morphology | 8.24e-04 | 910 | 25 | 7 | MP:0003743 | |
| MousePheno | abnormal interatrial septum morphology | 8.87e-04 | 107 | 25 | 3 | MP:0000282 | |
| MousePheno | pericardial effusion | 9.87e-04 | 111 | 25 | 3 | MP:0005312 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 1.01e-03 | 112 | 25 | 3 | MP:0004808 | |
| MousePheno | abnormal ventricle myocardium morphology | 1.12e-03 | 116 | 25 | 3 | MP:0010499 | |
| MousePheno | abnormal spongiotrophoblast size | 1.13e-03 | 28 | 25 | 2 | MP:0012097 | |
| MousePheno | abnormal ear position | 1.13e-03 | 28 | 25 | 2 | MP:0000023 | |
| MousePheno | decreased primordial germ cell number | 1.21e-03 | 29 | 25 | 2 | MP:0008392 | |
| MousePheno | abnormal fibroblast physiology | 1.27e-03 | 271 | 25 | 4 | MP:0020414 | |
| MousePheno | abnormal cell proliferation | 1.36e-03 | 1294 | 25 | 8 | MP:0000350 | |
| MousePheno | delayed bone ossification | 1.46e-03 | 127 | 25 | 3 | MP:0000060 | |
| MousePheno | cleft secondary palate | 1.46e-03 | 127 | 25 | 3 | MP:0009890 | |
| MousePheno | decreased fibroblast proliferation | 1.52e-03 | 129 | 25 | 3 | MP:0011704 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.53e-03 | 489 | 25 | 5 | MP:0010630 | |
| MousePheno | abnormal vascular branching morphogenesis | 1.57e-03 | 33 | 25 | 2 | MP:0003227 | |
| MousePheno | abnormal primordial germ cell morphology | 1.57e-03 | 33 | 25 | 2 | MP:0008391 | |
| MousePheno | increased liver glycogen level | 1.66e-03 | 34 | 25 | 2 | MP:0010400 | |
| MousePheno | prenatal lethality, incomplete penetrance | 1.69e-03 | 747 | 25 | 6 | MP:0011101 | |
| MousePheno | abnormal fibrous joint morphology | 1.73e-03 | 135 | 25 | 3 | MP:0030878 | |
| MousePheno | abnormal grooming behavior | 1.81e-03 | 137 | 25 | 3 | MP:0001440 | |
| Domain | Nuc_rcpt_coact | 4.78e-08 | 6 | 26 | 3 | IPR009110 | |
| Domain | - | 1.86e-06 | 2 | 26 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.86e-06 | 2 | 26 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.86e-06 | 2 | 26 | 2 | PS50134 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.86e-06 | 2 | 26 | 2 | IPR024670 | |
| Domain | BAF250_C | 1.86e-06 | 2 | 26 | 2 | IPR033388 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.86e-06 | 2 | 26 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.86e-06 | 2 | 26 | 2 | PF08214 | |
| Domain | BAF250_C | 1.86e-06 | 2 | 26 | 2 | PF12031 | |
| Domain | KIX | 1.86e-06 | 2 | 26 | 2 | PS50952 | |
| Domain | BCL9 | 1.86e-06 | 2 | 26 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 1.86e-06 | 2 | 26 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.86e-06 | 2 | 26 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.86e-06 | 2 | 26 | 2 | IPR013178 | |
| Domain | DUF902 | 1.86e-06 | 2 | 26 | 2 | PF06001 | |
| Domain | BAF250/Osa | 1.86e-06 | 2 | 26 | 2 | IPR021906 | |
| Domain | - | 1.86e-06 | 2 | 26 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.86e-06 | 2 | 26 | 2 | IPR010303 | |
| Domain | KAT11 | 1.86e-06 | 2 | 26 | 2 | SM01250 | |
| Domain | - | 1.86e-06 | 2 | 26 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 1.86e-06 | 2 | 26 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.86e-06 | 2 | 26 | 2 | IPR003101 | |
| Domain | Creb_binding | 1.86e-06 | 2 | 26 | 2 | PF09030 | |
| Domain | KIX | 1.86e-06 | 2 | 26 | 2 | PF02172 | |
| Domain | Bcl-9 | 1.86e-06 | 2 | 26 | 2 | IPR015668 | |
| Domain | CBP_P300_HAT | 1.86e-06 | 2 | 26 | 2 | PS51727 | |
| Domain | MOZ_SAS | 1.86e-05 | 5 | 26 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 1.86e-05 | 5 | 26 | 2 | IPR002717 | |
| Domain | MYST_HAT | 1.86e-05 | 5 | 26 | 2 | PS51726 | |
| Domain | H15 | 1.44e-04 | 13 | 26 | 2 | SM00526 | |
| Domain | H15 | 1.44e-04 | 13 | 26 | 2 | PS51504 | |
| Domain | PHD | 1.51e-04 | 75 | 26 | 3 | PF00628 | |
| Domain | Histone_H1/H5_H15 | 1.68e-04 | 14 | 26 | 2 | IPR005818 | |
| Domain | Znf_PHD-finger | 1.77e-04 | 79 | 26 | 3 | IPR019787 | |
| Domain | - | 1.93e-04 | 15 | 26 | 2 | 1.10.150.60 | |
| Domain | ARID | 1.93e-04 | 15 | 26 | 2 | PF01388 | |
| Domain | BRIGHT | 1.93e-04 | 15 | 26 | 2 | SM00501 | |
| Domain | ARID_dom | 1.93e-04 | 15 | 26 | 2 | IPR001606 | |
| Domain | ARID | 1.93e-04 | 15 | 26 | 2 | PS51011 | |
| Domain | PHD | 2.51e-04 | 89 | 26 | 3 | SM00249 | |
| Domain | Znf_PHD | 2.68e-04 | 91 | 26 | 3 | IPR001965 | |
| Domain | ZF_ZZ_2 | 2.81e-04 | 18 | 26 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.81e-04 | 18 | 26 | 2 | PS01357 | |
| Domain | ZZ | 2.81e-04 | 18 | 26 | 2 | PF00569 | |
| Domain | ZF_PHD_2 | 3.04e-04 | 95 | 26 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 3.14e-04 | 96 | 26 | 3 | PS01359 | |
| Domain | Znf_ZZ | 3.14e-04 | 19 | 26 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.14e-04 | 19 | 26 | 2 | SM00291 | |
| Domain | - | 3.40e-04 | 449 | 26 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.76e-04 | 459 | 26 | 5 | IPR013083 | |
| Domain | Bromodomain_CS | 5.93e-04 | 26 | 26 | 2 | IPR018359 | |
| Domain | LisH | 6.89e-04 | 28 | 26 | 2 | IPR006594 | |
| Domain | LisH | 6.89e-04 | 28 | 26 | 2 | SM00667 | |
| Domain | LISH | 6.89e-04 | 28 | 26 | 2 | PS50896 | |
| Domain | Znf_FYVE_PHD | 1.09e-03 | 147 | 26 | 3 | IPR011011 | |
| Domain | BROMODOMAIN_1 | 1.20e-03 | 37 | 26 | 2 | PS00633 | |
| Domain | Bromodomain | 1.27e-03 | 38 | 26 | 2 | PF00439 | |
| Domain | - | 1.41e-03 | 40 | 26 | 2 | 3.40.630.30 | |
| Domain | BROMODOMAIN_2 | 1.48e-03 | 41 | 26 | 2 | PS50014 | |
| Domain | BROMO | 1.55e-03 | 42 | 26 | 2 | SM00297 | |
| Domain | Bromodomain | 1.55e-03 | 42 | 26 | 2 | IPR001487 | |
| Domain | - | 1.55e-03 | 42 | 26 | 2 | 1.20.920.10 | |
| Domain | Acyl_CoA_acyltransferase | 1.78e-03 | 45 | 26 | 2 | IPR016181 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.86e-08 | 22 | 23 | 4 | MM1370 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.86e-08 | 26 | 23 | 4 | MM14793 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.73e-07 | 272 | 23 | 7 | M29619 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.08e-07 | 91 | 23 | 5 | M27101 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.42e-07 | 330 | 23 | 7 | M7847 | |
| Pathway | REACTOME_ADIPOGENESIS | 7.94e-07 | 110 | 23 | 5 | M48259 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.33e-06 | 122 | 23 | 5 | M29689 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.68e-06 | 237 | 23 | 6 | M27786 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.36e-06 | 137 | 23 | 5 | M48232 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.52e-06 | 254 | 23 | 6 | M27131 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.05e-06 | 18 | 23 | 3 | M26942 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.41e-06 | 65 | 23 | 4 | M39682 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.51e-06 | 24 | 23 | 3 | M13404 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 9.53e-06 | 84 | 23 | 4 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.31e-05 | 91 | 23 | 4 | M39700 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.35e-05 | 29 | 23 | 3 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.50e-05 | 30 | 23 | 3 | M207 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.55e-05 | 95 | 23 | 4 | M48268 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.54e-05 | 5 | 23 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.54e-05 | 5 | 23 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.54e-05 | 5 | 23 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.54e-05 | 5 | 23 | 2 | M48023 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZFHX3 ARID1B KMT2D ARID1A CREBBP WDR33 EP300 SMAD1 KAT6A TNRC6A | 2.83e-05 | 1387 | 23 | 10 | M734 |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.84e-05 | 37 | 23 | 3 | M27797 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.12e-05 | 233 | 23 | 5 | M27099 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.65e-05 | 118 | 23 | 4 | M27316 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA3 NCOA6 ARID1B KMT2D ARID1A SS18 CREBBP EP300 SMAD1 TNRC6A | 3.75e-05 | 1432 | 23 | 10 | M509 |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.80e-05 | 6 | 23 | 2 | M22062 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 4.18e-05 | 42 | 23 | 3 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.18e-05 | 42 | 23 | 3 | M27272 | |
| Pathway | PID_HNF3A_PATHWAY | 4.81e-05 | 44 | 23 | 3 | M285 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.32e-05 | 7 | 23 | 2 | MM1573 | |
| Pathway | REACTOME_HEME_SIGNALING | 6.66e-05 | 49 | 23 | 3 | M41832 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.09e-05 | 8 | 23 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 7.09e-05 | 8 | 23 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 7.09e-05 | 8 | 23 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 7.09e-05 | 8 | 23 | 2 | M46443 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 7.53e-05 | 142 | 23 | 4 | M27233 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 8.43e-05 | 53 | 23 | 3 | MM15880 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 9.08e-05 | 149 | 23 | 4 | M27888 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 9.10e-05 | 9 | 23 | 2 | M47451 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 9.42e-05 | 55 | 23 | 3 | M39351 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.14e-04 | 10 | 23 | 2 | M27945 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.14e-04 | 158 | 23 | 4 | MM14791 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.16e-04 | 59 | 23 | 3 | M39886 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.36e-04 | 1022 | 23 | 8 | MM15436 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.39e-04 | 11 | 23 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.39e-04 | 11 | 23 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.39e-04 | 11 | 23 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.66e-04 | 12 | 23 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.66e-04 | 12 | 23 | 2 | M27765 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.69e-04 | 175 | 23 | 4 | MM14941 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.93e-04 | 70 | 23 | 3 | M938 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.29e-04 | 14 | 23 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.64e-04 | 15 | 23 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.64e-04 | 15 | 23 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.64e-04 | 15 | 23 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 2.64e-04 | 15 | 23 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 2.64e-04 | 15 | 23 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.01e-04 | 16 | 23 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.01e-04 | 16 | 23 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.01e-04 | 16 | 23 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.01e-04 | 16 | 23 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.01e-04 | 16 | 23 | 2 | M27940 | |
| Pathway | PID_CMYB_PATHWAY | 3.32e-04 | 84 | 23 | 3 | M195 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 3.41e-04 | 17 | 23 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.41e-04 | 17 | 23 | 2 | M48025 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.55e-04 | 86 | 23 | 3 | M2642 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 4.05e-04 | 220 | 23 | 4 | M27794 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.28e-04 | 19 | 23 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 4.28e-04 | 19 | 23 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.75e-04 | 20 | 23 | 2 | M27881 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 4.91e-04 | 96 | 23 | 3 | M27792 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 4.91e-04 | 96 | 23 | 3 | M27784 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 5.06e-04 | 97 | 23 | 3 | M48262 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 5.25e-04 | 21 | 23 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 5.25e-04 | 21 | 23 | 2 | M27485 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 5.54e-04 | 239 | 23 | 4 | MM14756 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 5.77e-04 | 22 | 23 | 2 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.31e-04 | 23 | 23 | 2 | M2821 | |
| Pathway | WP_ANGIOGENESIS | 6.88e-04 | 24 | 23 | 2 | M39556 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 7.31e-04 | 110 | 23 | 3 | MM15977 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.47e-04 | 25 | 23 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 8.08e-04 | 26 | 23 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 8.08e-04 | 26 | 23 | 2 | M32 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 8.72e-04 | 27 | 23 | 2 | M26943 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 9.18e-04 | 119 | 23 | 3 | M607 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 9.38e-04 | 28 | 23 | 2 | M48253 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 9.38e-04 | 28 | 23 | 2 | M27254 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.01e-03 | 29 | 23 | 2 | MM15340 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.08e-03 | 30 | 23 | 2 | M27637 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.08e-03 | 30 | 23 | 2 | M936 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.15e-03 | 31 | 23 | 2 | M39522 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.16e-03 | 768 | 23 | 6 | MM14851 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.23e-03 | 32 | 23 | 2 | M39521 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.23e-03 | 296 | 23 | 4 | M27869 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.31e-03 | 301 | 23 | 4 | MM15983 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.38e-03 | 34 | 23 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 1.38e-03 | 34 | 23 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.38e-03 | 34 | 23 | 2 | MM15531 | |
| Pubmed | BCL9L NCOA3 NCOA6 ZFHX3 R3HDM2 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP WDR33 CAPRIN1 EP300 TNRC6A | 5.44e-18 | 1429 | 26 | 17 | 35140242 | |
| Pubmed | ATXN2L NCOA3 R3HDM2 ZMIZ1 BCL9 SSBP3 CREBBP WDR33 EP300 TNRC6A | 9.42e-18 | 152 | 26 | 10 | 38360978 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP WDR33 EP300 TNRC6A | 1.88e-16 | 457 | 26 | 12 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA3 NCOA6 ZFHX3 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP EP300 | 6.38e-16 | 351 | 26 | 11 | 38297188 |
| Pubmed | 1.81e-15 | 157 | 26 | 9 | 30186101 | ||
| Pubmed | 2.16e-13 | 83 | 26 | 7 | 28794006 | ||
| Pubmed | 2.33e-13 | 268 | 26 | 9 | 33640491 | ||
| Pubmed | 3.32e-12 | 57 | 26 | 6 | 18022353 | ||
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 10673036 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 3.71e-10 | 3 | 26 | 3 | 11823864 | |
| Pubmed | 5.26e-10 | 638 | 26 | 9 | 31182584 | ||
| Pubmed | 6.00e-10 | 425 | 26 | 8 | 24999758 | ||
| Pubmed | 1.18e-09 | 20 | 26 | 4 | 11877444 | ||
| Pubmed | 1.46e-09 | 21 | 26 | 4 | 19596656 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 16227615 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 33589584 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 28398509 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 1.48e-09 | 4 | 26 | 3 | 10655477 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 11701890 | ||
| Pubmed | 3.16e-09 | 78 | 26 | 5 | 28611094 | ||
| Pubmed | ATXN2L NCOA3 NCOA6 ARID1B KMT2D BCL9 ARID1A CREBBP CAPRIN1 EP300 | 3.31e-09 | 1103 | 26 | 10 | 34189442 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZFHX3 ZMIZ1 SSBP3 ARID1A KAT6B NFAT5 CREBBP EP300 MAEA ROR2 KAT6A | 3.64e-09 | 1489 | 26 | 11 | 28611215 |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 17182677 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 11912212 | ||
| Pubmed | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. | 3.70e-09 | 5 | 26 | 3 | 11239394 | |
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 3.70e-09 | 5 | 26 | 3 | 10497242 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.73e-09 | 180 | 26 | 6 | 35198878 | |
| Pubmed | 4.46e-09 | 549 | 26 | 8 | 38280479 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.59e-09 | 341 | 26 | 7 | 32971831 | |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 7.41e-09 | 6 | 26 | 3 | 11076796 | |
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 10887155 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.24e-08 | 220 | 26 | 6 | 35785414 | |
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 23540691 | ||
| Pubmed | 2.07e-08 | 8 | 26 | 3 | 17475621 | ||
| Pubmed | 2.07e-08 | 8 | 26 | 3 | 10490106 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.20e-08 | 40 | 26 | 4 | 34585037 | |
| Pubmed | 3.11e-08 | 9 | 26 | 3 | 16801560 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 4.43e-08 | 10 | 26 | 3 | 16751102 | |
| Pubmed | 4.43e-08 | 10 | 26 | 3 | 11163245 | ||
| Pubmed | 6.09e-08 | 11 | 26 | 3 | 18003620 | ||
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 6.09e-08 | 11 | 26 | 3 | 16096645 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.36e-08 | 774 | 26 | 8 | 15302935 | |
| Pubmed | 6.67e-08 | 1116 | 26 | 9 | 31753913 | ||
| Pubmed | 8.12e-08 | 12 | 26 | 3 | 12189208 | ||
| Pubmed | 8.12e-08 | 12 | 26 | 3 | 11734557 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 8.12e-08 | 12 | 26 | 3 | 14645221 | |
| Pubmed | 1.34e-07 | 14 | 26 | 3 | 12482968 | ||
| Pubmed | 1.42e-07 | 332 | 26 | 6 | 37433992 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 9267036 | ||
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 1.68e-07 | 15 | 26 | 3 | 17255939 | |
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 23785148 | ||
| Pubmed | 1.71e-07 | 66 | 26 | 4 | 23275444 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 19183483 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 28291835 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.10e-07 | 398 | 26 | 6 | 35016035 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 27881875 | ||
| Pubmed | New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. | 5.37e-07 | 2 | 26 | 2 | 17296583 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 5.37e-07 | 2 | 26 | 2 | 34845315 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 34386776 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19729597 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 23202128 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15860545 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 29460469 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 28675294 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 5.37e-07 | 2 | 26 | 2 | 24551300 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33890484 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 33911074 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9018065 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24648406 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30135524 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 5.37e-07 | 2 | 26 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 5.37e-07 | 2 | 26 | 2 | 29217654 | |
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 5.37e-07 | 2 | 26 | 2 | 24562383 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20717166 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 10049825 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 38811552 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 5.37e-07 | 2 | 26 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 5.37e-07 | 2 | 26 | 2 | 29170789 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 25893291 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11559821 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 5.37e-07 | 2 | 26 | 2 | 12646247 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 27185879 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 15371335 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 32576962 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19822209 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 24522976 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 5.37e-07 | 2 | 26 | 2 | 21847097 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 8595911 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 5.37e-07 | 2 | 26 | 2 | 37611161 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 5.37e-07 | 2 | 26 | 2 | 11963968 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 5.37e-07 | 2 | 26 | 2 | 29890703 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 5.37e-07 | 2 | 26 | 2 | 34813504 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 5.37e-07 | 2 | 26 | 2 | 12696060 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 11030627 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20301699 | ||
| Interaction | SP7 interactions | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A SS18 CREBBP WDR33 EP300 | 1.41e-17 | 304 | 26 | 13 | int:SP7 |
| Interaction | TBR1 interactions | BCL9L NCOA3 ZFHX3 ARID1B KMT2D ZMIZ1 BCL9 SSBP3 ARID1A EP300 | 1.01e-16 | 113 | 26 | 10 | int:TBR1 |
| Interaction | ETV4 interactions | 1.12e-16 | 69 | 26 | 9 | int:ETV4 | |
| Interaction | TBXT interactions | NCOA3 NCOA6 ARID1B KMT2D BCL9 SSBP3 ARID1A SS18 CREBBP EP300 | 1.32e-16 | 116 | 26 | 10 | int:TBXT |
| Interaction | PAX7 interactions | NCOA3 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A SS18 CREBBP EP300 | 2.63e-16 | 124 | 26 | 10 | int:PAX7 |
| Interaction | GATA2 interactions | NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A SS18 CREBBP EP300 | 4.47e-16 | 199 | 26 | 11 | int:GATA2 |
| Interaction | GSC interactions | 1.00e-15 | 87 | 26 | 9 | int:GSC | |
| Interaction | CRX interactions | BCL9L NCOA3 ZFHX3 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP EP300 ROR2 | 6.71e-15 | 254 | 26 | 11 | int:CRX |
| Interaction | EGR2 interactions | BCL9L NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 ARID1A CREBBP EP300 | 7.01e-15 | 171 | 26 | 10 | int:EGR2 |
| Interaction | TLX1 interactions | NCOA3 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A CREBBP EP300 KAT6A | 8.86e-15 | 175 | 26 | 10 | int:TLX1 |
| Interaction | ALG13 interactions | NCOA3 R3HDM2 ARID1B KMT2D BCL9 ARID1A WDR33 EP300 ROR2 TNRC6A | 1.39e-14 | 183 | 26 | 10 | int:ALG13 |
| Interaction | GCM1 interactions | 1.63e-14 | 68 | 26 | 8 | int:GCM1 | |
| Interaction | TLX3 interactions | BCL9L NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A EP300 ROR2 | 3.00e-14 | 291 | 26 | 11 | int:TLX3 |
| Interaction | FEV interactions | NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A CREBBP EP300 | 3.97e-14 | 203 | 26 | 10 | int:FEV |
| Interaction | PAX9 interactions | 4.16e-14 | 130 | 26 | 9 | int:PAX9 | |
| Interaction | NUP35 interactions | BCL9L NCOA3 NCOA6 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP WDR33 EP300 TNRC6A | 4.77e-14 | 424 | 26 | 12 | int:NUP35 |
| Interaction | EYA4 interactions | ATXN2L NCOA3 R3HDM2 ZMIZ1 BCL9 SSBP3 CREBBP WDR33 EP300 TNRC6A | 2.42e-13 | 243 | 26 | 10 | int:EYA4 |
| Interaction | SOX9 interactions | 3.12e-13 | 97 | 26 | 8 | int:SOX9 | |
| Interaction | TLE3 interactions | BCL9L NCOA3 ZFHX3 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP EP300 TNRC6A | 4.96e-13 | 376 | 26 | 11 | int:TLE3 |
| Interaction | SOX2 interactions | BCL9L ATXN2L NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 SSBP3 ARID1A KAT6B SS18 CAPRIN1 EP300 MAEA TNRC6A | 9.40e-13 | 1422 | 26 | 16 | int:SOX2 |
| Interaction | PAX8 interactions | 9.43e-13 | 111 | 26 | 8 | int:PAX8 | |
| Interaction | MYOD1 interactions | 1.60e-12 | 194 | 26 | 9 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.67e-12 | 195 | 26 | 9 | int:KLF5 | |
| Interaction | FOS interactions | NCOA3 NCOA6 ARID1B KMT2D BCL9 ARID1A NFAT5 SS18 CREBBP EP300 | 2.92e-12 | 312 | 26 | 10 | int:FOS |
| Interaction | SMAD3 interactions | ATXN2L NCOA3 NCOA6 ZFHX3 ARID1B ZMIZ1 ARID1A CREBBP EP300 SMAD1 KAT6A | 3.24e-12 | 447 | 26 | 11 | int:SMAD3 |
| Interaction | SMG7 interactions | NCOA3 NCOA6 R3HDM2 ARID1B KMT2D BCL9 ARID1A CREBBP CAPRIN1 TNRC6A | 3.64e-12 | 319 | 26 | 10 | int:SMG7 |
| Interaction | ERG interactions | 5.61e-12 | 223 | 26 | 9 | int:ERG | |
| Interaction | IRF4 interactions | 1.14e-11 | 85 | 26 | 7 | int:IRF4 | |
| Interaction | PAX6 interactions | NCOA3 NCOA6 ZFHX3 ARID1B KMT2D BCL9 ARID1A CREBBP EP300 SMAD1 | 1.42e-11 | 366 | 26 | 10 | int:PAX6 |
| Interaction | FOXI1 interactions | 2.01e-11 | 92 | 26 | 7 | int:FOXI1 | |
| Interaction | SOX17 interactions | 2.53e-11 | 95 | 26 | 7 | int:SOX17 | |
| Interaction | SS18L1 interactions | 3.15e-11 | 98 | 26 | 7 | int:SS18L1 | |
| Interaction | AR interactions | BCL9L NCOA3 NCOA6 ZFHX3 ARID1B KMT2D ZMIZ1 BCL9 ARID1A CREBBP WDR33 EP300 SMAD1 | 5.28e-11 | 992 | 26 | 13 | int:AR |
| Interaction | LHX2 interactions | 5.39e-11 | 183 | 26 | 8 | int:LHX2 | |
| Interaction | NFIA interactions | 6.68e-11 | 188 | 26 | 8 | int:NFIA | |
| Interaction | HNF1B interactions | 7.27e-11 | 190 | 26 | 8 | int:HNF1B | |
| Interaction | ETS1 interactions | 1.41e-10 | 121 | 26 | 7 | int:ETS1 | |
| Interaction | SOX15 interactions | 4.16e-10 | 141 | 26 | 7 | int:SOX15 | |
| Interaction | NFIB interactions | 4.37e-10 | 142 | 26 | 7 | int:NFIB | |
| Interaction | SOX7 interactions | 8.13e-10 | 82 | 26 | 6 | int:SOX7 | |
| Interaction | E2F5 interactions | 8.72e-10 | 36 | 26 | 5 | int:E2F5 | |
| Interaction | KLF4 interactions | 1.01e-09 | 160 | 26 | 7 | int:KLF4 | |
| Interaction | HNF4A interactions | 1.37e-09 | 275 | 26 | 8 | int:HNF4A | |
| Interaction | SOX10 interactions | 1.64e-09 | 92 | 26 | 6 | int:SOX10 | |
| Interaction | TEAD1 interactions | 1.97e-09 | 176 | 26 | 7 | int:TEAD1 | |
| Interaction | GATA3 interactions | 3.00e-09 | 187 | 26 | 7 | int:GATA3 | |
| Interaction | EWSR1 interactions | BCL9L NCOA3 NCOA6 BCL9 SSBP3 ARID1A PNISR CREBBP EP300 SMAD1 KAT6A | 5.93e-09 | 906 | 26 | 11 | int:EWSR1 |
| Interaction | TPRX2 interactions | 8.68e-09 | 56 | 26 | 5 | int:TPRX2 | |
| Interaction | SMARCC2 interactions | 9.71e-09 | 353 | 26 | 8 | int:SMARCC2 | |
| Interaction | NCOA6 interactions | 2.56e-08 | 145 | 26 | 6 | int:NCOA6 | |
| Interaction | CREBBP interactions | 3.39e-08 | 599 | 26 | 9 | int:CREBBP | |
| Interaction | YAP1 interactions | BCL9L ATXN2L NCOA6 ARID1B KMT2D ARID1A NFAT5 CREBBP WDR33 EP300 SMAD1 | 4.21e-08 | 1095 | 26 | 11 | int:YAP1 |
| Interaction | ARID1A interactions | 4.41e-08 | 276 | 26 | 7 | int:ARID1A | |
| Interaction | LHX4 interactions | 5.73e-08 | 166 | 26 | 6 | int:LHX4 | |
| Interaction | SMARCE1 interactions | 5.76e-08 | 287 | 26 | 7 | int:SMARCE1 | |
| Interaction | RBBP5 interactions | 5.76e-08 | 287 | 26 | 7 | int:RBBP5 | |
| Interaction | IRF1 interactions | 6.45e-08 | 83 | 26 | 5 | int:IRF1 | |
| Interaction | GATA1 interactions | 6.84e-08 | 171 | 26 | 6 | int:GATA1 | |
| Interaction | LHX3 interactions | 1.09e-07 | 185 | 26 | 6 | int:LHX3 | |
| Interaction | HOXB2 interactions | 1.25e-07 | 36 | 26 | 4 | int:HOXB2 | |
| Interaction | LHX1 interactions | 1.91e-07 | 103 | 26 | 5 | int:LHX1 | |
| Interaction | CNOT3 interactions | 2.12e-07 | 207 | 26 | 6 | int:CNOT3 | |
| Interaction | SMARCB1 interactions | 2.90e-07 | 364 | 26 | 7 | int:SMARCB1 | |
| Interaction | LDB1 interactions | 3.31e-07 | 115 | 26 | 5 | int:LDB1 | |
| Interaction | KLF3 interactions | 3.74e-07 | 228 | 26 | 6 | int:KLF3 | |
| Interaction | PYGO2 interactions | 4.07e-07 | 48 | 26 | 4 | int:PYGO2 | |
| Interaction | DDIT3 interactions | 4.10e-07 | 120 | 26 | 5 | int:DDIT3 | |
| Interaction | SMARCC1 interactions | 4.16e-07 | 384 | 26 | 7 | int:SMARCC1 | |
| Interaction | MEX3A interactions | 4.16e-07 | 384 | 26 | 7 | int:MEX3A | |
| Interaction | SMAD2 interactions | 4.23e-07 | 385 | 26 | 7 | int:SMAD2 | |
| Interaction | EYA2 interactions | 4.27e-07 | 121 | 26 | 5 | int:EYA2 | |
| Interaction | SMAD1 interactions | 5.43e-07 | 243 | 26 | 6 | int:SMAD1 | |
| Interaction | HDAC1 interactions | ZFHX3 KMT2D ZMIZ1 ARID1A SS18 CREBBP CAPRIN1 EP300 SMAD1 TNRC6A | 5.73e-07 | 1108 | 26 | 10 | int:HDAC1 |
| Interaction | MDC1 interactions | 6.89e-07 | 414 | 26 | 7 | int:MDC1 | |
| Interaction | SNIP1 interactions | 7.23e-07 | 417 | 26 | 7 | int:SNIP1 | |
| Interaction | WWTR1 interactions | 7.83e-07 | 422 | 26 | 7 | int:WWTR1 | |
| Interaction | LHX6 interactions | 8.81e-07 | 58 | 26 | 4 | int:LHX6 | |
| Interaction | MED23 interactions | 9.22e-07 | 266 | 26 | 6 | int:MED23 | |
| Interaction | SSBP4 interactions | 9.44e-07 | 59 | 26 | 4 | int:SSBP4 | |
| Interaction | TLX2 interactions | 9.45e-07 | 142 | 26 | 5 | int:TLX2 | |
| Interaction | NCOA1 interactions | 1.08e-06 | 146 | 26 | 5 | int:NCOA1 | |
| Interaction | ELF5 interactions | 1.12e-06 | 147 | 26 | 5 | int:ELF5 | |
| Interaction | SMARCA4 interactions | 1.43e-06 | 462 | 26 | 7 | int:SMARCA4 | |
| Interaction | PUM1 interactions | 1.43e-06 | 287 | 26 | 6 | int:PUM1 | |
| Interaction | KLF15 interactions | 1.52e-06 | 290 | 26 | 6 | int:KLF15 | |
| Interaction | CEBPA interactions | ATXN2L NCOA3 NCOA6 ARID1B KMT2D BCL9 ARID1A CREBBP CAPRIN1 EP300 | 1.67e-06 | 1245 | 26 | 10 | int:CEBPA |
| Interaction | NEUROG1 interactions | 1.82e-06 | 19 | 26 | 3 | int:NEUROG1 | |
| Interaction | NANOG interactions | 1.87e-06 | 481 | 26 | 7 | int:NANOG | |
| Interaction | NR3C1 interactions | 2.06e-06 | 974 | 26 | 9 | int:NR3C1 | |
| Interaction | PPARG interactions | 2.12e-06 | 307 | 26 | 6 | int:PPARG | |
| Interaction | KMT2D interactions | 2.23e-06 | 169 | 26 | 5 | int:KMT2D | |
| Interaction | SETD1A interactions | 2.29e-06 | 170 | 26 | 5 | int:SETD1A | |
| Interaction | KLF13 interactions | 2.50e-06 | 21 | 26 | 3 | int:KLF13 | |
| Interaction | EPAS1 interactions | 2.50e-06 | 173 | 26 | 5 | int:EPAS1 | |
| Interaction | CTNNB1 interactions | 2.75e-06 | 1009 | 26 | 9 | int:CTNNB1 | |
| Interaction | ARID1B interactions | 2.80e-06 | 177 | 26 | 5 | int:ARID1B | |
| Interaction | RUNX1 interactions | 2.89e-06 | 324 | 26 | 6 | int:RUNX1 | |
| Interaction | DTX2 interactions | 3.22e-06 | 330 | 26 | 6 | int:DTX2 | |
| Interaction | HNF1A interactions | 3.22e-06 | 80 | 26 | 4 | int:HNF1A | |
| Interaction | MEN1 interactions | 3.24e-06 | 1029 | 26 | 9 | int:MEN1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 4.82e-03 | 183 | 26 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 6.18e-03 | 208 | 26 | 2 | chr10q22 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.67e-12 | 17 | 16 | 5 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.29e-06 | 25 | 16 | 3 | 775 | |
| GeneFamily | PHD finger proteins | 6.37e-05 | 90 | 16 | 3 | 88 | |
| GeneFamily | AT-rich interaction domain containing | 7.66e-05 | 15 | 16 | 2 | 418 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 8.75e-05 | 16 | 16 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-04 | 18 | 16 | 2 | 91 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.64e-07 | 466 | 26 | 7 | M13522 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.06e-07 | 300 | 26 | 6 | M8702 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 4.30e-07 | 157 | 26 | 5 | M7733 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATXN2L NCOA3 KMT2D ARID1A KAT6B PNISR NFAT5 CREBBP EP300 KAT6A | 7.95e-07 | 1492 | 26 | 10 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.16e-06 | 856 | 26 | 8 | M4500 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 1.39e-06 | 199 | 26 | 5 | M4526 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 3.38e-06 | 988 | 26 | 8 | M6616 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 5.42e-06 | 734 | 26 | 7 | M3835 | |
| Coexpression | GARY_CD5_TARGETS_UP | 5.67e-06 | 473 | 26 | 6 | M17693 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.14e-05 | 822 | 26 | 7 | M6782 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.47e-05 | 323 | 26 | 5 | M9150 | |
| Coexpression | BENPORATH_NOS_TARGETS | 2.80e-05 | 179 | 26 | 4 | M14573 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.86e-05 | 180 | 26 | 4 | M8239 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 2.98e-05 | 634 | 26 | 6 | M40866 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | 3.68e-05 | 192 | 26 | 4 | M7571 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 3.68e-05 | 192 | 26 | 4 | M8272 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 3.98e-05 | 196 | 26 | 4 | M5381 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.23e-05 | 199 | 26 | 4 | M9420 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 4.23e-05 | 199 | 26 | 4 | M5726 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 4.31e-05 | 200 | 26 | 4 | M9472 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 4.31e-05 | 200 | 26 | 4 | M4352 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 4.97e-05 | 417 | 26 | 5 | M39224 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 8.11e-05 | 85 | 26 | 3 | M41085 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 8.49e-05 | 467 | 26 | 5 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.00e-04 | 484 | 26 | 5 | MM999 | |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_DN | 1.60e-04 | 19 | 26 | 2 | M3323 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 1.81e-04 | 290 | 26 | 4 | M17183 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 1.91e-04 | 294 | 26 | 4 | M40873 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 2.12e-04 | 905 | 26 | 6 | M40865 | |
| Coexpression | SMITH_TERT_TARGETS_UP | 3.93e-04 | 145 | 26 | 3 | M17742 | |
| Coexpression | GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB | 3.93e-04 | 145 | 26 | 3 | M2137 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 3.93e-04 | 145 | 26 | 3 | M1810 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 5.01e-04 | 685 | 26 | 5 | MM3782 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 5.52e-04 | 35 | 26 | 2 | M13814 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_329_3P_GENES | 5.52e-04 | 35 | 26 | 2 | MM17501 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_DN | 5.63e-04 | 164 | 26 | 3 | M10311 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 5.83e-04 | 166 | 26 | 3 | M15535 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 6.07e-04 | 399 | 26 | 4 | M40939 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 6.35e-04 | 171 | 26 | 3 | M8594 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_LB_DN | 7.21e-04 | 40 | 26 | 2 | M13569 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 7.49e-04 | 181 | 26 | 3 | M6849 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 7.49e-04 | 181 | 26 | 3 | M8662 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 7.86e-04 | 184 | 26 | 3 | M6593 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.16e-04 | 432 | 26 | 4 | M41149 | |
| Coexpression | GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN | 8.62e-04 | 190 | 26 | 3 | M6589 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 8.72e-04 | 44 | 26 | 2 | M2377 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP | 9.02e-04 | 193 | 26 | 3 | M9056 | |
| Coexpression | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN | 9.12e-04 | 45 | 26 | 2 | M950 | |
| Coexpression | IKEDA_MIR133_TARGETS_UP | 9.12e-04 | 45 | 26 | 2 | MM929 | |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN | 9.16e-04 | 194 | 26 | 3 | M7580 | |
| Coexpression | GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN | 9.16e-04 | 194 | 26 | 3 | M6908 | |
| Coexpression | KRASNOSELSKAYA_ILF3_TARGETS_DN | 9.53e-04 | 46 | 26 | 2 | M12166 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 9.57e-04 | 197 | 26 | 3 | M5853 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN | 9.57e-04 | 197 | 26 | 3 | M5877 | |
| Coexpression | GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN | 9.71e-04 | 198 | 26 | 3 | M5507 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 9.71e-04 | 198 | 26 | 3 | M8440 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 9.71e-04 | 198 | 26 | 3 | M5293 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 9.85e-04 | 199 | 26 | 3 | M7254 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 9.85e-04 | 199 | 26 | 3 | M7319 | |
| Coexpression | GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP | 9.85e-04 | 199 | 26 | 3 | M7142 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 9.85e-04 | 199 | 26 | 3 | M3151 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 9.85e-04 | 199 | 26 | 3 | M4444 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 9.85e-04 | 199 | 26 | 3 | M7374 | |
| Coexpression | GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN | 9.85e-04 | 199 | 26 | 3 | M7390 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN | 1.00e-03 | 200 | 26 | 3 | M9408 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.00e-03 | 200 | 26 | 3 | M5063 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 1.00e-03 | 200 | 26 | 3 | M5059 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M9449 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 1.00e-03 | 200 | 26 | 3 | M7256 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 1.00e-03 | 200 | 26 | 3 | M3374 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 1.00e-03 | 200 | 26 | 3 | M5991 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 1.00e-03 | 200 | 26 | 3 | M4667 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_DN | 1.00e-03 | 200 | 26 | 3 | M3355 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M8050 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.00e-03 | 200 | 26 | 3 | M9847 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN | 1.00e-03 | 200 | 26 | 3 | M7205 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.00e-03 | 200 | 26 | 3 | M3659 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 1.00e-03 | 200 | 26 | 3 | M5851 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M4819 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP | 1.00e-03 | 200 | 26 | 3 | M9278 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.00e-03 | 200 | 26 | 3 | M7908 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN | 1.00e-03 | 200 | 26 | 3 | M3547 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.00e-03 | 200 | 26 | 3 | M5216 | |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 1.13e-03 | 50 | 26 | 2 | M1702 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 1.26e-03 | 53 | 26 | 2 | M6303 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.31e-03 | 54 | 26 | 2 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.31e-03 | 54 | 26 | 2 | M2372 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.33e-03 | 221 | 26 | 3 | M39222 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | 1.46e-03 | 506 | 26 | 4 | M253 | |
| Coexpression | SANSOM_APC_MYC_TARGETS | 1.71e-03 | 241 | 26 | 3 | M1756 | |
| Coexpression | SANSOM_APC_MYC_TARGETS | 1.73e-03 | 242 | 26 | 3 | MM736 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | 1.88e-03 | 542 | 26 | 4 | M19529 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 2.12e-03 | 946 | 26 | 5 | M39169 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 2.16e-03 | 563 | 26 | 4 | M15103 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.83e-07 | 259 | 26 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 3.05e-06 | 790 | 26 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 3.38e-06 | 801 | 26 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 3.54e-06 | 806 | 26 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.14e-06 | 99 | 26 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 6.23e-06 | 390 | 26 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 2.86e-05 | 769 | 26 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 3.09e-05 | 149 | 26 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 3.43e-05 | 791 | 26 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 3.81e-05 | 804 | 26 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.17e-04 | 210 | 26 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.18e-04 | 406 | 26 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.19e-04 | 407 | 26 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.28e-04 | 413 | 26 | 5 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_100 | 1.61e-04 | 87 | 26 | 3 | gudmap_developingGonad_e11.5_testes_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.73e-04 | 89 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.84e-04 | 91 | 26 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 1.99e-04 | 241 | 26 | 4 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 3.52e-04 | 806 | 26 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.74e-04 | 815 | 26 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 3.81e-04 | 818 | 26 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.16e-04 | 120 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 4.48e-04 | 843 | 26 | 6 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.30e-04 | 312 | 26 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.38e-04 | 564 | 26 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.54e-04 | 330 | 26 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.86e-04 | 595 | 26 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.37e-04 | 146 | 26 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.97e-04 | 150 | 26 | 3 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.23e-04 | 362 | 26 | 4 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 9.79e-04 | 161 | 26 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 9.86e-04 | 38 | 26 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 9.96e-04 | 162 | 26 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 1.05e-03 | 165 | 26 | 3 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.05e-03 | 375 | 26 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 1.09e-03 | 40 | 26 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.13e-03 | 382 | 26 | 4 | GSM476684_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200 | 1.33e-03 | 179 | 26 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200 | 1.37e-03 | 181 | 26 | 3 | gudmap_developingGonad_e11.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.41e-03 | 406 | 26 | 4 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.45e-03 | 409 | 26 | 4 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.48e-03 | 186 | 26 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_100 | 1.64e-03 | 49 | 26 | 2 | gudmap_developingGonad_e11.5_testes_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 1.70e-03 | 50 | 26 | 2 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 1.70e-03 | 50 | 26 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.85e-03 | 201 | 26 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 1.90e-03 | 203 | 26 | 3 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.07e-03 | 209 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 2.13e-03 | 56 | 26 | 2 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | 2.21e-03 | 774 | 26 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 2.26e-03 | 778 | 26 | 5 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 2.30e-03 | 217 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 2.48e-03 | 795 | 26 | 5 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.51e-03 | 797 | 26 | 5 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.54e-03 | 799 | 26 | 5 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.61e-03 | 62 | 26 | 2 | gudmap_developingGonad_e11.5_testes_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.71e-03 | 230 | 26 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.75e-03 | 231 | 26 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.81e-03 | 818 | 26 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 2.82e-03 | 819 | 26 | 5 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.84e-03 | 492 | 26 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.97e-03 | 498 | 26 | 4 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 3.04e-03 | 67 | 26 | 2 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.22e-03 | 844 | 26 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.39e-03 | 249 | 26 | 3 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.56e-03 | 524 | 26 | 4 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.78e-03 | 533 | 26 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.79e-03 | 75 | 26 | 2 | gudmap_developingGonad_e14.5_ ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 4.09e-03 | 78 | 26 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.48e-03 | 275 | 26 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.57e-03 | 277 | 26 | 3 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 4.73e-03 | 84 | 26 | 2 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.76e-03 | 281 | 26 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.90e-03 | 284 | 26 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.10e-03 | 288 | 26 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 5.17e-03 | 88 | 26 | 2 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_200 | 5.17e-03 | 88 | 26 | 2 | gudmap_developingGonad_e12.5_testes_k5_200 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.90e-10 | 186 | 26 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.90e-10 | 186 | 26 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.46e-06 | 192 | 26 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 192 | 26 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.56e-06 | 193 | 26 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.41e-05 | 147 | 26 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.06e-04 | 159 | 26 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 167 | 26 | 3 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 167 | 26 | 3 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 167 | 26 | 3 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 170 | 26 | 3 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 170 | 26 | 3 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.66e-04 | 185 | 26 | 3 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.69e-04 | 186 | 26 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-04 | 190 | 26 | 3 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.82e-04 | 191 | 26 | 3 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.88e-04 | 193 | 26 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.94e-04 | 195 | 26 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 195 | 26 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.03e-04 | 198 | 26 | 3 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.03e-04 | 198 | 26 | 3 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.03e-04 | 198 | 26 | 3 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.63e-13 | 170 | 26 | 9 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.25e-11 | 172 | 26 | 8 | 1072_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.58e-11 | 177 | 26 | 8 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.54e-10 | 173 | 26 | 7 | 3243_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.85e-10 | 174 | 26 | 7 | 1659_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.17e-10 | 175 | 26 | 7 | 1014_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.17e-10 | 175 | 26 | 7 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.85e-10 | 177 | 26 | 7 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.95e-10 | 180 | 26 | 7 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.70e-08 | 165 | 26 | 6 | 2835_DN | |
| Drug | glutamin | 3.02e-08 | 461 | 26 | 8 | CID000000738 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.34e-08 | 171 | 26 | 6 | 6879_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.58e-08 | 173 | 26 | 6 | 5950_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.97e-08 | 176 | 26 | 6 | 7499_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.97e-08 | 176 | 26 | 6 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.97e-08 | 176 | 26 | 6 | 981_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.97e-08 | 176 | 26 | 6 | 6932_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.10e-08 | 177 | 26 | 6 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.24e-08 | 178 | 26 | 6 | 7245_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 4.24e-08 | 178 | 26 | 6 | 4444_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.24e-08 | 178 | 26 | 6 | 1112_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.53e-08 | 180 | 26 | 6 | 6886_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.53e-08 | 180 | 26 | 6 | 4541_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.69e-08 | 181 | 26 | 6 | 6951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 4.84e-08 | 182 | 26 | 6 | 1951_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.17e-08 | 184 | 26 | 6 | 6939_DN | |
| Drug | AC1L1COZ | 5.31e-08 | 90 | 26 | 5 | CID000001996 | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A | 7.99e-08 | 198 | 26 | 6 | 1797_DN | |
| Drug | TiNi | 9.03e-08 | 100 | 26 | 5 | CID000159408 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.03e-06 | 163 | 26 | 5 | 7453_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.03e-06 | 163 | 26 | 5 | 7285_DN | |
| Drug | AC1L2E0P | 1.05e-06 | 307 | 26 | 6 | CID000019390 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.09e-06 | 165 | 26 | 5 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.13e-06 | 166 | 26 | 5 | 2247_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.20e-06 | 168 | 26 | 5 | 3868_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.23e-06 | 169 | 26 | 5 | 5231_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-06 | 169 | 26 | 5 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-06 | 169 | 26 | 5 | 6064_DN | |
| Drug | In-G | 1.27e-06 | 170 | 26 | 5 | CID000446054 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.27e-06 | 170 | 26 | 5 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.30e-06 | 171 | 26 | 5 | 2777_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 4112_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 6439_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 1637_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-06 | 172 | 26 | 5 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.38e-06 | 173 | 26 | 5 | 4237_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.38e-06 | 173 | 26 | 5 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.38e-06 | 173 | 26 | 5 | 5987_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.38e-06 | 173 | 26 | 5 | 5336_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.38e-06 | 173 | 26 | 5 | 4458_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.42e-06 | 174 | 26 | 5 | 3462_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.42e-06 | 174 | 26 | 5 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.42e-06 | 174 | 26 | 5 | 5693_DN | |
| Drug | C2SI | 1.49e-06 | 20 | 26 | 3 | CID006327160 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.50e-06 | 176 | 26 | 5 | 3312_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.50e-06 | 176 | 26 | 5 | 5976_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.50e-06 | 176 | 26 | 5 | 1535_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.55e-06 | 177 | 26 | 5 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.55e-06 | 177 | 26 | 5 | 5308_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.55e-06 | 177 | 26 | 5 | 7550_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.55e-06 | 177 | 26 | 5 | 3227_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.59e-06 | 178 | 26 | 5 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.63e-06 | 179 | 26 | 5 | 4483_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.68e-06 | 180 | 26 | 5 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.68e-06 | 180 | 26 | 5 | 1793_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.77e-06 | 182 | 26 | 5 | 1891_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.25e-06 | 191 | 26 | 5 | 7503_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.37e-06 | 193 | 26 | 5 | 2477_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 2.43e-06 | 194 | 26 | 5 | 3674_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 2.49e-06 | 195 | 26 | 5 | 1318_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 2.68e-06 | 198 | 26 | 5 | 2839_DN | |
| Drug | anacardic acid | 5.26e-06 | 30 | 26 | 3 | CID000167551 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.25e-05 | 5 | 26 | 2 | ctd:C575894 | |
| Drug | AC1L1G5B | 1.94e-05 | 46 | 26 | 3 | CID000003531 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.19e-05 | 161 | 26 | 4 | 4768_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.35e-05 | 163 | 26 | 4 | 5594_DN | |
| Drug | AC1N0FHX | 3.50e-05 | 8 | 26 | 2 | CID003916227 | |
| Drug | AC1LCVO8 | 3.50e-05 | 8 | 26 | 2 | CID000656891 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.51e-05 | 165 | 26 | 4 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.59e-05 | 166 | 26 | 4 | 7324_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.59e-05 | 166 | 26 | 4 | 2268_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.68e-05 | 167 | 26 | 4 | 5217_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.77e-05 | 168 | 26 | 4 | 3395_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.94e-05 | 170 | 26 | 4 | 3746_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.94e-05 | 170 | 26 | 4 | 5417_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.04e-05 | 171 | 26 | 4 | 7407_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.04e-05 | 171 | 26 | 4 | 1000_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.04e-05 | 171 | 26 | 4 | 5441_DN | |
| Drug | khellin | 4.04e-05 | 171 | 26 | 4 | CID000003828 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.04e-05 | 171 | 26 | 4 | 3297_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.04e-05 | 171 | 26 | 4 | 4954_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.13e-05 | 172 | 26 | 4 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.13e-05 | 172 | 26 | 4 | 6993_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.22e-05 | 173 | 26 | 4 | 4665_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 3993_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 1302_UP | |
| Disease | breast carcinoma (is_marker_for) | 3.29e-07 | 66 | 26 | 4 | DOID:3459 (is_marker_for) | |
| Disease | T-Cell Lymphoma | 3.38e-07 | 16 | 26 | 3 | C0079772 | |
| Disease | Menke-Hennekam syndrome | 7.47e-07 | 2 | 26 | 2 | cv:C5681632 | |
| Disease | Acute myeloid leukemia with t(8;16)(p11;p13) translocation | 7.47e-07 | 2 | 26 | 2 | C4511003 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.47e-07 | 2 | 26 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 7.47e-07 | 2 | 26 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.47e-07 | 2 | 26 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.47e-07 | 2 | 26 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.47e-07 | 2 | 26 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.47e-07 | 2 | 26 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 7.47e-07 | 2 | 26 | 2 | C0035934 | |
| Disease | Sezary Syndrome | 1.75e-06 | 27 | 26 | 3 | C0036920 | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-06 | 100 | 26 | 4 | C0010606 | |
| Disease | Malignant neoplasm of breast | 2.61e-06 | 1074 | 26 | 8 | C0006142 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.33e-06 | 41 | 26 | 3 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 6.33e-06 | 41 | 26 | 3 | C0007138 | |
| Disease | Breast adenocarcinoma | 6.33e-06 | 41 | 26 | 3 | C0858252 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 6.50e-06 | 139 | 26 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 6.69e-06 | 140 | 26 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.88e-06 | 141 | 26 | 4 | C0005684 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 7.45e-06 | 5 | 26 | 2 | C3281201 | |
| Disease | testosterone measurement | 9.25e-06 | 1275 | 26 | 8 | EFO_0004908 | |
| Disease | Prostatic Neoplasms | 1.30e-05 | 616 | 26 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.30e-05 | 616 | 26 | 6 | C0376358 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.55e-05 | 55 | 26 | 3 | C0079744 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.47e-05 | 195 | 26 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | neuroblastoma (is_implicated_in) | 3.35e-05 | 10 | 26 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 5.79e-05 | 13 | 26 | 2 | C0265338 | |
| Disease | Lymphoma, Large-Cell, Follicular | 7.78e-05 | 15 | 26 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 7.78e-05 | 15 | 26 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 7.78e-05 | 15 | 26 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 7.78e-05 | 15 | 26 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 7.78e-05 | 15 | 26 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 7.78e-05 | 15 | 26 | 2 | C1956130 | |
| Disease | Squamous cell carcinoma of esophagus | 7.97e-05 | 95 | 26 | 3 | C0279626 | |
| Disease | body weight | 8.23e-05 | 1261 | 26 | 7 | EFO_0004338 | |
| Disease | Breast Carcinoma | 9.48e-05 | 538 | 26 | 5 | C0678222 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.20e-04 | 566 | 26 | 5 | EFO_0007660, EFO_0008354 | |
| Disease | Lymphoma, Follicular | 1.40e-04 | 20 | 26 | 2 | C0024301 | |
| Disease | neutrophil count | 1.46e-04 | 1382 | 26 | 7 | EFO_0004833 | |
| Disease | Squamous cell carcinoma | 1.75e-04 | 124 | 26 | 3 | C0007137 | |
| Disease | body surface area | 2.18e-04 | 643 | 26 | 5 | EFO_0022196 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.63e-04 | 670 | 26 | 5 | EFO_0006335, EFO_0006336 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.75e-04 | 364 | 26 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | breast cancer (is_implicated_in) | 3.07e-04 | 150 | 26 | 3 | DOID:1612 (is_implicated_in) | |
| Disease | caudate nucleus volume | 3.20e-04 | 30 | 26 | 2 | EFO_0004830 | |
| Disease | sexual dimorphism measurement | 3.31e-04 | 1106 | 26 | 6 | EFO_0021796 | |
| Disease | prostate cancer (is_marker_for) | 3.45e-04 | 156 | 26 | 3 | DOID:10283 (is_marker_for) | |
| Disease | taste liking measurement | 3.50e-04 | 388 | 26 | 4 | EFO_0010155 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 3.85e-04 | 398 | 26 | 4 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | colon cancer (is_implicated_in) | 4.62e-04 | 36 | 26 | 2 | DOID:219 (is_implicated_in) | |
| Disease | risk-taking behaviour | 4.81e-04 | 764 | 26 | 5 | EFO_0008579 | |
| Disease | vital capacity | 5.97e-04 | 1236 | 26 | 6 | EFO_0004312 | |
| Disease | metabolic syndrome | 7.11e-04 | 200 | 26 | 3 | EFO_0000195 | |
| Disease | Neuroblastoma | 7.88e-04 | 47 | 26 | 2 | C0027819 | |
| Disease | body fat percentage | 8.28e-04 | 488 | 26 | 4 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPVNQPAMGMNTGMN | 156 | Q09472 | |
| SNPAMQNMNPMQAGV | 2126 | Q09472 | |
| NPMSPQQHMLPNQAQ | 2276 | Q09472 | |
| LQSQPGMQPQPGMHQ | 2121 | Q92793 | |
| GMQPQPGMHQQPSLQ | 2126 | Q92793 | |
| LNIMNPGHNPNMASM | 2171 | Q92793 | |
| GAMAGMQYPQQQMPP | 651 | Q8NFD5 | |
| SAQPMNPTQNMDMPQ | 391 | Q14444 | |
| NPQQFPGQPAMMQPM | 791 | Q8WWM7 | |
| QPGLQPMMPNQQQAA | 556 | Q9Y2K5 | |
| PMMPNQQQAAYQGMI | 561 | Q9Y2K5 | |
| QPMQTPPHGNMMYTA | 2036 | Q8WYB5 | |
| NAQQNMPPQMMGGPI | 1471 | O14497 | |
| VMNENNPPMMLPNGY | 346 | Q7L5Y9 | |
| PPNMIFNPNQNPMAN | 1286 | O94916 | |
| PQNQMQVSHGPPNMM | 566 | Q14686 | |
| QVSHGPPNMMQPSLM | 571 | Q14686 | |
| PPNMMQPSLMGIHGN | 576 | Q14686 | |
| MPQGQMMVNPPSQNL | 656 | Q14686 | |
| KQMLSQQGPQMMAPH | 681 | Q14686 | |
| QQGPQMMAPHNQMMG | 686 | Q14686 | |
| AQIMRGPTPNMQGNM | 741 | Q14686 | |
| QPMQPNPHGNMMYTG | 1966 | Q92794 | |
| NLPSMNNMPGMGINT | 1046 | O00512 | |
| VDPPMGPGNLNMNMN | 761 | Q86UU0 | |
| QGHPNMGGSMQRMNP | 191 | Q9BWW4 | |
| GPSQNPMMQHPQAAS | 1341 | Q9Y6Q9 | |
| QIPMQMAPQQVPPQM | 841 | Q01974 | |
| QDGSQPMDTNMMAPP | 236 | Q15797 | |
| APHMQNQMNGQMPGP | 116 | Q15532 | |
| NQMNGQMPGPNHMPM | 121 | Q15532 | |
| NHMPMQGPGPNQLNM | 131 | Q15532 | |
| MSMQPNQGPMMHQQP | 196 | Q15532 | |
| QGQQPPMGMMGQVNQ | 226 | Q15532 | |
| MPSPQQQVMVGQMHR | 471 | Q9Y4G6 | |
| QQVMVGQMHRGHMPP | 476 | Q9Y4G6 | |
| QSMVEQPPGMMPNGQ | 51 | Q8TF01 | |
| FQQPHPSQQMPMNMA | 601 | Q9C0J8 | |
| PSQQMPMNMAQMGPP | 606 | Q9C0J8 | |
| STMNHPQMQAPSGMN | 486 | Q8NDV7 | |
| MANANNPMNPGGNPM | 186 | Q9ULJ6 | |
| ATMAMGPQQPPQQQQ | 3186 | Q15911 | |
| PPSMCMKPQQLAMQQ | 3386 | O14686 |